Don’t Be Fooled By Gain in Vaxart Inc. [VXRT] Stock

Vaxart Inc. [VXRT] shares are up more than 2376.19% this year and recently increased 0.01% or $0.08 to settle at $7.80. VXRT has a short ratio of 1.78. This implies that the market is currently less bullish on the outlook for VXRT.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .


On 16, November 2020, Vaxart Hosting Key Opinion Leader Panel Call for Investors. According to news published on Yahoo Finance, Title: An Oral Tablet Vaccine – A Potential Global Solution to COVID-19 and Norovirus.

Analyst Birdseye View:

The most recent analyst activity for Vaxart Inc. [NASDAQ:VXRT] stock was on July 13, 2020, when it was Initiated with a Buy rating from B. Riley FBR, which also raised its 12-month price target on the stock to $22. Before that, on August 12, 2020, H.C. Wainwright Recapitulated a Buy rating and elevated its amount target to $17.

In the past 52 weeks of trading, this stock has oscillated between a low of $0.28 and a peak of $17.49. Right now, according to Wall Street analyst the average 12-month amount target is $17.67. At the most recent market close, shares of Vaxart Inc. [NASDAQ:VXRT] were valued at $7.80.


Vaxart Inc. [NASDAQ:VXRT] most recently reported quarterly sales of 265.0 million, which represented growth of -40.00%. This publicly-traded organization’s revenue is $704,429 per employee, while its income is -$1,331,786 per employee. Continuing to look at profitability, this corporation’s Return on Assets, Equity, Whole Principal & invested Principal is sitting at -51.61, -154.15, -33.85 and -67.27 respectively.

If looking now at the Principal structure of this organization, it shows its whole liability to the whole Principal at 59.01 and the whole liability to whole assets at 50.35. It shows enduring liability to the whole principal at 47.12 and enduring liability to assets at 0.40 while looking for an extended time period.

Readers are usually of view to make a close observation to the indicators that support and make resistance before moving to any particular stock. As of now, the company’s stock is sitting at 7.55 points at 1st support level, the second support level is making up to 7.30. But as of 1st resistance point, this stock is sitting at 7.97 and at 8.14 for 2nd resistance point.

Vaxart Inc. [VXRT] reported its earnings at -$0.08 per share in the fiscal quarter closing of 9/29/2020. The Analysts for Wall Street were expecting to report its earnings at -$0.09/share signifying the difference of 0.01 and 11.10% surprise value. Comparing the previous quarter ending of 6/29/2020, the stated earnings were -$0.12 calling estimates for -$0.06/share with the difference of -0.06 depicting the surprise of -100.00%.

Important Ratio’s To Watch

Meanwhile, turning our focus to liquidity, the Current Ratio for Vaxart Inc. [NASDAQ:VXRT] is 13.20. Likewise, the Quick ratio is also the same, showing Cash ratio at 1.47. Now if looking for a valuation of this stock’s amount to sales ratio it’s 0.77 and it’s amount to book ratio is 1.31.

Insider Stories

The most recent insider trade was by Latour Wouter, Director, and it was the sale of 0.33 million shares on Nov 23. ARMISTICE CAPITAL, LLC, the Director, completed a sale of 9.39 million shares on Jun 29. On Jun 26, ARMISTICE CAPITAL, LLC, Director, completed a sale of 18.23 million shares.